# FDA recall D-0325-2024

> **IntegraDose Compounding Services LLC** · Class II · drug recall initiated 2024-01-22.

## Product

Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for Injection, Concentration: 1 Unit/mL, 2 mL Syringe, Rx Only, 719 Kasota Ave SE, Minneapolis, MN, Compounded Drug Not for Resale. Office Use Only, NDC 71139-0190-1.

## Reason for recall

Sub-potent drug: failure to maintain potency through the duration of the labeled expiration/beyond-use date.

## Distribution

MN

## Key facts

- **Recall number:** D-0325-2024
- **Recalling firm:** IntegraDose Compounding Services LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2024-01-22
- **Report date:** 2024-02-21

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Minneapolis, MN, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0325-2024

## Citation

> AI Analytics. FDA recall D-0325-2024. Retrieved 2026-08-11 from https://api.ai-analytics.org/recall/D-0325-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*